1st SERbian BIomarker Symposium (SERBIS)

Date: 
Thursday, January 28, 2016 - 09:30 to Friday, January 29, 2016 - 18:30
 
WELCOME ADDRESS
 
Dear Colleagues and Friends,
 
It is a great pleasure and honor to invite you to the 1st SERbian BIomarker Symposium  (SERBIS) that will be held in Belgrade, Serbia, on January 28-29, 2016. This international symposium is arranged to bridge clinical and laboratory work, emphasising the importance of teamwork and interactions between all professionals involved in the fight against cardiovascular disease and personalized medicine approache. The 1st SERBIS with the overall theme Biomarkers in Clinical Cardiology: Diagnosis, Treatment and Devices is intended to display the state of the biomarker use at the interface between Cardiology and Laboratory Medicine.
 
This symposium will bring together well-known experts from all-over Europe which will share their knowledge, experience, latest research and deliver state-of-the-art lectures in the area of clinical cardiology, circulating and imaging biomarkers, advances in analytical issues, recently published guidelines and evidence based therapies and treatment strategies.
 
We were planning an innovative and original programme to present, share, debate and conclude on the opportunity to improve diagnosis, risk stratification, and selection of therapy using noninvasive new biomarkers and new application of existing biomarkers in clinical cardiology.
 
We are convinced that SERBIS will be top level educational and scientific event in our region, giving to the participants an excellent opporunity for education and chance for improvement of personal achievements. It will offer a unique opportunity to identify new research ideas and establish collaboration with colleagues from different countries. Also, to keep up to date with Industry partners who will showcase their latest advances on their booths in biomarkers determination, therapy and devices in clinical cardiology.
 
We hope that SERBIS will meet your expectations, provide you some unforgettable personal and professional memories, and trust that you will enjoy your visit to the very beautiful and exciting city of Belgrade.
 
We look forward to welcoming you in Belgrade.
 
Sincerely yours,
Symposium directors
 
5 SLIKA
 
 
ORGANIZER
Clinical Center of Serbia
Center for Medical Biochemistry
Department of Cardiology
 
COORGANIZERS
Cardiology Section of the Serbian Medical Association
Board on Cardiovascular Pathology of the Serbian Academy of Sciences and Arts
 
HONORARY COMMITTEE
 
Ass. dr Zlatibor Lončar
 Minister of Health of the Republic of Serbia
 
Dr Srđan Verbić
 Minister of Education, Science and Technological Development of the Republic of Serbia
 
Academician Vladimir Kostić
President of Serbian Academy of Sciences and Arts
 
Academician Dragan Micić
President of Serbian Health Council
 
Academician Vladimir Kanjuh
President, Board on Cardiovascular Pathology of the Serbian Academy of Sciences and Arts
 
Academician Ljubiša Rakić
President, Board on Biomedical Investigation of the Serbian Academy of Sciences and Arts
 
Academician Radoje Čolović
President of Serbian Medical Association
 
Academician Vladimir Bumbaširević
Rector, University of Belgrade
 
Academician Jovan Hadži-Đokić
 
Academician Nebojša Lalić
Dean, University of Belgrade, School of Medicine
 
Prof. dr Zorica Vujić
Dean, University of Belgrade, School of Pharmacy
 
 
 
 
 
SCIENTIFIC COMMITTEE
 
Milika Ašanin
Tobias Breidthardt
Benjamin Dieplinger
Dragan Dinčić
Damien Gruson
Angelika Hammerer-Lercher
Branislava Ivanović
Vladimir Kanjuh
Gabor Kovacs
Paivi Laitinen
Nebojša Lalić
Vangelis Manolopoulos
Iacoviello Massimo
Christophe Meune
Goran Milašinović
Igor Mrdović
Aleksandar Nešković
Slobodan Obradović
Mauro Panteghini
Milan Pavlović
Tatjana Potpara
Kari Pulkki
Arsen Ristić
Ron H.N. van Schaik
Petar Seferović
 Grazyna Sipniewska
Salvatore Di Somma
Goran Stanković
Sanja Stanković
Branislav Stefanović
Dragana Šobić-Šaranović
Raphael Twerenbold
Vladan Vukčević
 
 
 
 
 
 
 
 
 
 
 
 
 
ORGANIZING COMMITTEE
 
Daniela Bartolović
Branko Beleslin
 Andjelo Beletić
Jasna Bjelanović
Emina Čolak
Ana Djordjevic-Dikić
 Anica Djordjević
Jelica Djordjević
Radica Dunjić
Olja Gabrić
Dimitra Kalimanovska-Oštrić
 Mirjana Milivojević
Predrag Mitrović
 Ivana Nedeljković
Milan Nedeljković
 Biljana Obrenović-Kirćanski
 Radmila Obrenović
Dejan Orlić
 Milan Petrović
 Dragan Simić
 Jelena Stepanović
 Vesna Stojanov
 Siniša Stojković
Gordana Stošić
Tatjana Vodnik
Bosiljka Vujisić-Tešić
Dragana Vukosavljević
 
 
UNDER THE AUSPICES OF
Ministry of Health of the Republic of Serbia
Ministry of Education, Science and Technological Development of Serbia
 
 
 
 
 
 
 
 
 
THURSDAY, JANUARY 28, 2016
 
 
 
 
 
 
 
 
08:30 -10:00
Registration
 
 
 
10:00-10:30
Opening ceremony
 
 
 
 
 
 
 
 
 
BIOMARKERS AND EVIDENCE-BASED MEDICINE
 
 
Chairs: Mauro Panteghini, Ron H.N. van Schaik,
Goran Stanković
 
 
 
10:30 -10:50
Biomarkers in recent international guidelines
 
Salvatore Di Somma
Rome, Italy
10:50 -11:10
Critical aspects of cardiac troponin use in clinical practice
 
Mauro Panteghini
Milano, Italy
11:10 -11:30
The use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe: The CARMAGUE study
 
Paivi Laitinen
Helsinki, Finland
11:30-11:50
Genetic biomarkers for optimizing drug therapy: the clinical value of pharmacogenetics
 
Ron H.N. van Schaik
 
Rotterdam, Netherlands
11:50-12:10
Pharmacogenomics of cardiovascular drugs
 
Vangelis Manolopoulos
Alexandroupolis, Greece
12:10-12:30
Q&A (Discussion)
 
 
 
 
 
 
 
 
12:30-13:00
Coffee break
 
 
 
 
 
 
 
 
 
BIOMARKERS FOR HEART FAILURE
 
 
Chairs: Salvatore di Somma, Petar Seferović, Sanja Stanković
 
 
 
13:00-13:20
ESC Guideline strategies for biomarkers use to guide management of heart failure patients
 
Petar Seferović  106252
Belgrade, Serbia
13:20-13:40
Natriuretic peptides in clinical practice
 
Tobias Breidthardt
Basel, Switzerland
13:40-14:00
How to improve heart failure management by using galectin-3?
 
Iacoviello Massimo
Bari, Italy
14:00-14:20
The role for novel biomarkers, ST2 and GDF-15, for diagnosis, risk assessment and/or therapeutic guidance in heart failure
 
Sanja Stanković
Belgrade, Serbia
14:20-14:40
Prognosis of heart failure: perspectives from the FGF-23/PTH/ Vitamin D axis
 
Damien Gruson
Brussels, Belgium
14:40-15:00
Copeptin in acute coronary syndromes and heart failure management: state of the art and future directions
 
Angelika Hammerer Lercher
Aarau, Switzerland
15:00-15:15
Q&A (Discussion)
 
 
 
 
 
 
 
 
15:15-15:45
Lunch symposium-Bayer
 
 
 
 
 
 
 
 
 
NOVEL ANTITHROMBOTIC AND ANTICOAGULATION THERAPY
 
 
Chairs: Goran Milašinović, Aleksandar Nešković, Branislava Ivanović
 
 
 
16:00-16:20
Ticagrelor: patients selection and optimal timing of initiation
 
Slobodan Obradović
Belgrade, Serbi
16:20-16:40
DAPT: optimal duration and monitoring
 
Aleksandar Nešković 108476
Belgrade, Serbia
16:40-17:00
Ventricular arrhythmias and prevention of sudden cardiac death
 
Goran Milašinović 106055
Belgrade, Serbia
17:00-17:20
Novel anticoagulation therapy in atrial fibrillation
 
Tatjana Potpara
Belgrade, Serbia
17:20-17:40
Novel anticoagulation therapy in prevention of deep venous thrombosis and pulmonary embolism
 
Branislava Ivanović 106103
Belgrade, Serbia
17:40-18:00
Triple therapy following myocardial revascularization: who, when, and how?
 
Milan Pavlović
Niš, Serbia
18:00-18:15
Q&A (Discussion)
 
 
 
 
 
 
 
 
 
FRIDAY, JANUARY 29, 2016
 
 
 
 
 
 
09:15-09:45
Symposium-Mylan
 
 
 
 
 
BIOMARKERS FOR ACUTE CORONARY SYNDROMES
 
 
Chairs: Nebojša Lalić, Christophe Meune, Grazyna Sipniewska
 
 
 
10:00-10:20
Biomarkers in risk stratification and management of patients with diabetes and metabolic syndrome
 
Nebojša Lalić 100368
Belgrade, Serbia
10:20-10:40
Short-term risk stratification for cardiac patients: emergency department and cardiology perspectives
 
Christophe Meune
Paris, France
 
10:40-11:00
Innovative approach to diagnosing acute myocardial infarction in 1-hour with high-sensitive cardiac troponin T 
 
Raphael Twerenbold
Basel, Switzerland
11:00-11:20
Paradigm Change with high sensitivity troponin assays 
 
Benjamin Dieplinger
Linz, Austria
11:20-11:40
High-sensitive troponins: analytical perspectives
 
Grazyna Sipniewska
Bydgoszcz, Poland
11:40-12:00
Troponin POCT assays in the diagnosis of myocardial infarction
 
Gabor Kovacs
Pécs, Hungary
12:00-12:20
Utility of H-FABP for the early diagnosis of acute coronary syndrome
 
Kari Pulkki
Kuopioo, Finland
12:20-12:45
Q&A (Discussion)
 
 
 
 
 
 
 
 
12:45-13:45
Lunch
 
 
 
 
 
 
 
BIOMARKERS AND MYOCARDIAL REVASCULARIZATION
 
 
Chairs: Vladimir Kanjuh, Dragana Šobić-Šaranović, Dragan Dinčić
 
 
 
14:00-14:20
Vulnerable plaque or vulnerable patient
 
Vladimir Kanjuh
Belgrade, Serbia
14:20-14:40
Integrated imaging in the selection of patients for myocardial revascularization
 
Dragana Šobić-Šaranović 105797
Belgrade, Serbia
14:40 -15:00
Controversies in defining periprocedural myocardial infarction
 
Goran Stankovic 101015
Belgrade, Serbia
15:00-15:20
Secondary prevention after myocardial revascularization
 
Dragan Dinčić 104980
Belgrade, Serbia
15:20-15:30
Q&A (Discussion)
 
 
 
 
 
 
 
 
15:30-16:00
Symposium- Astra Zeneca (kafa)
 
 
 
 
 
 
 
 
 
NEW GUIDELINES IN 2014/15: KEY MESSAGES FOR CLINICAL PRACTICE
 
 
Chairs:Arsen Ristić, Branislav Stefanović, Igor Mrdović
 
 
 
16:15-16.35
Differential diagnosis of acute chest pain
 
Vladan Vukčević  106224
Belgrade, Serbia
16:35-16:55
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
 
Igor Mrdović 106096
Belgrade, Serbia
16:55-17:15
Pulmonary embolism
 
Branislav Stefanović 106226
Belgrade, Serbia
17:15-17:35
Pericardial disease & pulmonary hypertension
 
Arsen Ristić  106253
Belgrade, Serbia
 
 
 
 
 
17:35-18:00
Summary and closing of the symposium
 
 
 
 
 
 
 
 
SYMPOSIUM VENUE
 
Hyatt Regency Belgrade is the finest ***** 5 star hotel in Belgrade.
Hotel address is Milentija Popovića 5 Street, 11 070 Belgrade, Serbia, phone +381 11 301 1234, fax +381 11 311 2234, e-mail belgrade.regency@hyatt.com, web link www.hyattregencybeograd.rs
 
GENERAL INFORMATION
 
CURRENCY
The Serbian currency is Serbian Dinar (abbreviated as RSD). Current exchange rate is about 121 RSD for 1 Euro. Credit cards (VISA, Euro card, MasterCard, American Express, Diners Club) are accepted in most shops. Automated Teller Machines (ATMs) and Exchange offices are also available in the Hotel. For detailed information contact Hotel reception.
 
PUBLIC TRANSPORTATION
Bus lines 68, 95, as well as tram lines 7, 7L, 9, 11 and 13 connect the Hotel with the City. The one way tickets are available in the buses and trams (cost 150 RSD, app. 1.2 Euro), and also the multiple use tickets can be acquired at kiosks in the front of the Center. Taxis are available throughout the City of Belgrade, and also in front of the Hotel.
 
WiFi
Free WiFi is provided for al Symposium participants. Choose option Hyatt internet, than option Conference, input code: meet/serbis thick terms of use and the end click authenticate.
 
WEATHER FORCAST
During the two days of the Symposium mostly cloudy weather is expected, and daily temperatures ranging from 0-3 °C (source: accuweather.com).  
 
SCIENTIFIC SECRETARIAT
Sanja Stanković, Goran Stanković, Arsen Ristić, Branislava Ivanović,  Clinical Center of Serbia,  Višegradska 26, 11000 Belgrade, Serbia, Phone/Fax: +381-11-361-5631, E-mail: cmb@kcs.ac.rs, Mobile phones: +381-66-8300-598 (Sanja Stanković), +381-66-8300-302 (Goran Stanković), +381-66-8300-340 (Arsen Ristić), +381-66-8300-352 (Branislava Ivanović).
 
TRAVEL AGENCY
For hotel reservations and travel arrangements please contact TCA travel agency (Ms. Radmila Kovačević or Ms. Katarina Kovačević, office phone +381-11-3238-514 or +381-11-3238-705, or mobile phone +381-063-300-719, E-mail: tca@beotel.net). Accommodation of the faculty members and international participants is organized at the Hyatt Regency Hotel. Transportation from the airport and from the hotels will be organized for all invited speakers and international participants.
 
LANGUAGE
The official language of the Symposium is English.
 
REGISTRATION
Registration desk will be opened on Thursday January 28th 2016, from 8:30 AM. Registration fee for participants is free of charge. Preregistered participants can pick up their name badges and Symposium material at the Registration desk from Thursday January 28th 2016, 8:30 AM.  Symposium speaker’s abstracts will be available at Symposium web site http://www.serbis.rs/.
 
CERTIFICATES OF ATTENDANCE
The Symposium program is accredited by the Medical Council of Serbia with 9 CME credit hours for participants and 15 for lecturers (No. 153-01-3890/2015-01, Ev.No. А-1-3176/15). Certificates of attendance will be available at the Registration Desk, on Friday, January 29, 2016 from 06:00 PM.
 
DOWLOAD PROGRAM FROM THE SYMPOSIUM WEBSITE: http://www.serbis.rs/
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PRINCIPAL SPONSOR
 
PLATINUM SPONSOR
ASTRA                  BAYER
 
GOLD SPONSOR
ABBOTT            INTERLAB        LABTEH
 
 SILVER SPONSOR
ACTAVIS    ADOC  BIOMERIEUX    MERCK  PFIZER                     
SPONSORS OF SCIENTIFIC SYMPOSIA
   MYLAN
SPONSORS
ALKALOID    ALURA  BOEHRINGER KRKA
PHARMASWISS  SUPERLAB

 

Tags: